Delivery Order SPE2DB25D3306-SPE2DB25FUCHE
Award Date 7/22/25
Potential Completion Date 7/23/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $2,337.32 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product, with a completion date of June 23, 2025. The contract is not set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
- This is a $6,244.74 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a pharmaceutical product. The contract has a completion date of July 3, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product, with a ceiling value of $1,020.88. The contract has an ultimate completion date of June 10, 2025 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a pharmaceutical product. The contract has a ceiling value of $1,210.78 and a period of performance through May 8, 2025. It is a firm-fixed price delivery order contract, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
- This federal contract award, valued at $5,434.89, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a medical product. The contract has an ultimate completion date of March 3, 2025 and is a Firm Fixed Price Delivery Order. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of the pharmaceutical product ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, with a total ceiling value of $11,494.51. The contract is a firm fixed-price, non-set-aside contract with a period of performance through May 6, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no information provided about any...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML medical products. The contract has a ceiling value of $3,367.82 and a completion date of January 3, 2025. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $2,071.18 and a period of performance through July 2, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp is the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,020.88, is a delivery order for the medical product "ADBRY 300 MG/2 ML AUTOINJECTOR 2ML". The contract has an ultimate completion date of April 10, 2025 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,655.46 firm fixed-price delivery order contract is for the supply of the medication ADBRY 300 MG/2 ML AUTOINJECTOR 2ML, with a period of performance through March 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...